X4 Pharmaceuticals, Inc. buy HC Wainwright
Start price
22.03.24
/
50%
€1.35
Target price
22.03.25
€2.78
Performance (%)
-19.33%
Price
26.04.24
€1.09
Summary
This prediction is currently active. The prediction for X4 Pharmaceuticals, Inc. disappoints with a performance of -19.33%. This prediction currently runs until 22.03.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
X4 Pharmaceuticals, Inc. | -7.555% | -7.555% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by HC_Wainwright for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Ratings data for XFOR provided by MarketBeat
Stopped prediction by HC_Wainwright for X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€0.95
11.08.23
11.08.23
€2.73
11.08.24
11.08.24
15.24%
26.04.24
26.04.24